1. Current antiacne treatment and contraindications in pregnant women

   Newsletter Article 17 February 2013 Pages: 2 - 2

2. Tardive dyskinesia: an overview

   Newsletter Article 17 February 2013 Pages: 2 - 3

3. Cocaine toxicity: the role of adulterants

   Newsletter Article 17 February 2013 Pages: 3 - 3

4. Antimalarials

   Newsletter Article 17 February 2013 Pages: 4 - 4

5. Antipsychotics

   Newsletter Article 17 February 2013 Pages: 4 - 4

6. Aspirin

   Newsletter Article 17 February 2013 Pages: 4 - 4

7. Benzathine benzylpenicillin overdose

   Newsletter Article 17 February 2013 Pages: 4 - 4

8. Cefazolin

   Newsletter Article 17 February 2013 Pages: 4 - 4

9. Chloroquine

   Newsletter Article 17 February 2013 Pages: 4 - 4

10. Chloroquine/hydroxychloroquine

    Newsletter Article 17 February 2013 Pages: 4 - 4

11. Chlorpromazine

    Newsletter Article 17 February 2013 Pages: 4 - 5

12. Chlorpromazine see Pipotiazine/chlorpromazine

    Newsletter Article 17 February 2013 Pages: 5 - 5

13. Clorazepate see Viloxazine/clorazepate overdose

    Newsletter Article 17 February 2013 Pages: 5 - 5

14. Cocaine

    Newsletter Article 17 February 2013 Pages: 5 - 5

15. Cocaine abuse

    Newsletter Article 17 February 2013 Pages: 5 - 5

16. Cytarabine

    Newsletter Article 17 February 2013 Pages: 5 - 5

17. Dexamethasone

    Newsletter Article 17 February 2013 Pages: 5 - 5

18. Diamorphine abuse

    Newsletter Article 17 February 2013 Pages: 5 - 5

19. Enalapril

    Newsletter Article 17 February 2013 Pages: 5 - 5

20. Enalapril interaction

    Newsletter Article 17 February 2013 Pages: 6 - 6

21. Etretinate

    Newsletter Article 17 February 2013 Pages: 6 - 6

22. Etretinate see Isotretinoin/etretinate

    Newsletter Article 17 February 2013 Pages: 6 - 6

23. Flumazenil

    Newsletter Article 17 February 2013 Pages: 6 - 6

24. Fluphenazine

    Newsletter Article 17 February 2013 Pages: 6 - 6

25. Furosemide

    Newsletter Article 17 February 2013 Pages: 6 - 6

26. Ganciclovir/zidovudine

    Newsletter Article 17 February 2013 Pages: 6 - 7

27. Glafenine

    Newsletter Article 17 February 2013 Pages: 7 - 7

28. Haloperidol

    Newsletter Article 17 February 2013 Pages: 7 - 7

29. Heparin

    Newsletter Article 17 February 2013 Pages: 7 - 7

30. Heparin

    Newsletter Article 17 February 2013 Pages: 7 - 7

31. Hydrochloroquine see Chloroquine/hydroxychloroquine

    Newsletter Article 17 February 2013 Pages: 7 - 7

32. Insulin, human

    Newsletter Article 17 February 2013 Pages: 7 - 7

33. Isoniazid see Theophylline interaction see Warfarin interaction

    Newsletter Article 17 February 2013 Pages: 7 - 7

34. Isotretinoin/etretinate

    Newsletter Article 17 February 2013 Pages: 7 - 7

35. Lovastatin

    Newsletter Article 17 February 2013 Pages: 7 - 7

36. Mesoridazine overdose

    Newsletter Article 17 February 2013 Pages: 8 - 8

37. Metoclopramide

    Newsletter Article 17 February 2013 Pages: 8 - 8

38. Pancuronium bromide interaction

    Newsletter Article 17 February 2013 Pages: 8 - 9

39. Phenytoin see Pancuronium bromide interaction

    Newsletter Article 17 February 2013 Pages: 9 - 9

40. Phenytoin interaction

    Newsletter Article 17 February 2013 Pages: 9 - 9

41. Potassium chloride

    Newsletter Article 17 February 2013 Pages: 9 - 9

42. Pipotiazine/chlorpromazine

    Newsletter Article 17 February 2013 Pages: 9 - 9

43. Propofol

    Newsletter Article 17 February 2013 Pages: 9 - 9

44. Rifampicin see Enalapril interaction see Phenytoin interaction see Theophylline interaction see Warfarin interaction

    Newsletter Article 17 February 2013 Pages: 9 - 9

45. Sucralfate interaction

    Newsletter Article 17 February 2013 Pages: 10 - 10

46. Theophylline interaction

    Newsletter Article 17 February 2013 Pages: 10 - 10

47. Trifluoperazine

    Newsletter Article 17 February 2013 Pages: 10 - 10

48. Viloxazine/clorazepate overdose

    Newsletter Article 17 February 2013 Pages: 10 - 10

49. Warfarin

    Newsletter Article 17 February 2013 Pages: 10 - 12

50. Warfarin interaction

    Newsletter Article 17 February 2013 Pages: 12 - 12